[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
February 2006

Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy—Reply

Arch Neurol. 2006;63(2):301. doi:10.1001/archneur.63.2.301

In reply

We thank Dr Pijak for his comments. Risk of stroke and recurrent stroke1 is related to inflammatory markers. We agree that “rebound” inflammatory mechanisms may also play a role in the higher-than-expected increase of ischemic strokes2 and coronary syndromes3 after discontinuation of aspirin. This hypothesis is supported by the increased efficacy of aspirin in patients with high C-reactive protein levels.4 Chiang et al5 have even found that low-dose aspirin in volunteers had anti-inflammatory but not antiplatelet action. It is likely that both mechanisms, and probably even others, play a role in the antithrombotic effect of aspirin.

First Page Preview View Large
First page PDF preview
First page PDF preview
×